Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Endocrinology and Metabolism|September 29, 2005
Tumor deletion mapping on chromosome 11q13 in eight families with isolated familial somatotropinoma and in 15 sporadic somatotropinomasBeatriz S Soares, Kuniki Eguchi, Lawrence A Frohman
The Journal of Clinical Endocrinology and Metabolism|August 24, 2013
Efficacy and safety of an octreotide implant in the treatment of patients with acromegalyCarla Chieffo, David Cook, Qinfang Xiang, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|April 24, 2009
Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjectsLucila Sackmann-Sala, Juan Ding, Lawrence A Frohman, et al.
Neuroendocrinology|October 26, 2005
Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) miceSeungjoon Park, Xiao-ding Peng, Lawrence A Frohman, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 13, 2012
A subcutaneous octreotide hydrogel implant for the treatment of acromegalyMônica R Gadelha, Carla Chieffo, Stephen A Bai, et al.
Trends in Endocrinology and Metabolism: TEM|June 24, 2010
Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA)Harvinder S Chahal, J Paul Chapple, Lawrence A Frohman, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2005
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsSam L Teichman, Ann Neale, Betty Lawrence, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 11, 2006
Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouseMaria Alba, Danilo Fintini, Alessia Sagazio, et al.
Pituitary|April 25, 2012
Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumorFederica Guaraldi, Valentina Corazzini, Gary L Gallia, et al.
Endocrinology|April 4, 2009
Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivationRaul M Luque, Beatriz S Soares, Xiao-ding Peng, et al.
Pageof 3